Medical News

RSS

Substance abuse treatment facilities offering nicotine replacement therapy increased by 6%: Report

The percentage of substance abuse treatment facilities offering nicotine replacement therapy to clients gradually increased by about 6 percentage points from 2006 to 2009, according to a new Spotlight report issued by the Substance Abuse and Mental Health Services Administration released in conjunction with the "Great American Smokeout."

19 Nov 2010

Insight Health Services sells seven imaging centers

InSight Health Services Holdings Corp. today announced that it has completed the previously announced sale of seven imaging centers. Six centers were located in El Paso, Texas and Las Cruces, New Mexico and one imaging center in California.

19 Nov 2010

Report examines how health care reform affects personal costs, coverage, quality of service

Although most people's knowledge of the new health care law is limited, their opinion on how it will affect their health care depends on what type of private health insurance plan they currently have and their political affiliation, according to a recent report issued today by the nonpartisan Employee Benefit Research Institute.

19 Nov 2010

Glenn Foundation awards $60,000 grant to Scripps' scientist for biomedical research

While scientists depend on grants for their research, applying for them is a long and frequently frustrating process. For one Scripps Research Institute scientist, however, the process was shorter.

19 Nov 2010

Stromedix obtains license from UCSF for integrin αvβ5 antibody

Stromedix, Inc., a biotechnology company focused on innovative therapies for fibrosis and organ failure, announced today that it has exclusively licensed the rights to a monoclonal antibody to integrin αvβ5 from the University of California. This compound is the second Stromedix pipeline asset to be sourced from the laboratory of Dean Sheppard, M.D., at University of California, San Francisco.

19 Nov 2010

MedStart Summer Enrichment Program helps students better understand medical conditions: Studies

Two new studies have shown that a unique program in East Harlem that helps middle school students learn practical health skills and gain a better understanding of medical conditions, such as diabetes and hypertension, resulted in increased interest in college attendance and medical careers among the students who attended the program.

19 Nov 2010

SAMHSA: 4.8% U.S. adults suffer from serious mental illness

According to new results from a national survey, 19.9 percent of American adults in the United States (45.1 million) have experienced mental illness over the past year. The survey conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA) indicates that 11 million adults (4.8 percent) in the U.S. suffered serious mental illness in the past year a diagnosable mental disorder has substantially interfered with, or limited one or more major life activities.

19 Nov 2010

ENERCA network organizes European Symposium on rare anemias

It is estimated that rare diseases -those whose frequency is under 5 cases / 10,000 people- affect about 6% of the European population. In the field of anemia, 1% of couples are at risk of having a newborn with a severe syndrome of hemoglobin. More than 330,000 children are born worldwide each year affected by one of these diseases, being the most common disorders sickle cell anemia and thalassemia syndromes.

19 Nov 2010

Living in deprived area increases risk of violence more sharply for girls than boys: Study

Living in a deprived area increases the risk of violence more sharply for girls than boys, according to a Cardiff University study of former industrial areas.

19 Nov 2010

AVEO's RON antibody shows anti-tumor activity in human cancer xenografts

AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced preclinical data from AVEO's anti-RON antibody program which demonstrated the successful identification of antibodies with potent anti-tumor activity that demonstrated inhibition of the function of both wild type RON and the RONΔ160 variant, as well as a potential biomarker to identify tumors likely to respond to treatment with the anti-RON antibody.

19 Nov 2010

Fifth gene defect, 47 DNA regions linked to thoracic aortic disease: Researchers

Discovery of a fifth gene defect and the identification of 47 DNA regions linked to thoracic aortic disease are the subject of studies released this month involving researchers at The University of Texas Health Science Center at Houston.

19 Nov 2010

ZIOPHARM announces data on darinaparsin efficacy for solid tumors at EORTC-NCI-AACR Symposium

ZIOPHARM Oncology, Inc. announced today important new preclinical data on the efficacy of darinaparsin (ZinaparTM, or ZIO-101) in various solid tumor models delivered at the EORTC-NCI-AACR International Symposium on Molecular Targets and Cancer Therapeutics being held in Berlin, Germany.

19 Nov 2010

Acacia subsidiary receives patents for wireless physiological monitoring technology

Acacia Research Corporation announced today that a subsidiary has acquired 11 patents for wireless physiological monitoring technology.

19 Nov 2010

ImmunoGen presents positive data on IMGN388 anticancer compound at EORTC-NCI-AACR Symposium

ImmunoGen, Inc., a biotechnology company that develops antibody-based anticancer products using its Targeted Antibody Payload (TAP) technology, today announced the presentation of encouraging clinical data for the Company's IMGN388 anticancer compound at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics taking place in Berlin, Germany.

19 Nov 2010

Physical activity may protect high-risk individuals from cognitive decline: Study

Physical activity promotes changes in the brain that may protect high-risk individuals against cognitive decline, including development of Alzheimer's disease, according to a new study done at the University of Wisconsin-Milwaukee (UWM).

19 Nov 2010

Research suggests new therapeutic approach to prevent transplant rejection

UCLA researchers have pinpointed the culprit behind chronic rejection of heart, lung and kidney transplants. Published in the Nov. 23 edition of Science Signaling, their findings suggest new therapeutic approaches for preventing transplant rejection and sabotaging cancer growth.

19 Nov 2010

New handbooks provide health benefits information to Veterans

The Department of Veterans Affairs (VA) is piloting new, personalized Veterans Health Benefits Handbooks. The handbooks are tailored to provide enrolled Veterans with the most relevant health benefits information based on their own specific eligibility. In essence, each handbook will be written for the individual Veteran.

19 Nov 2010

Illness perception related to concurrent depression symptoms: Research

New research findings which highlight the detrimental effect of depression on patients with end-stage kidney disease has celebrated at the University of Hertfordshire 2010 Awards Ceremonies yesterday (17 November 2010) at the Cathedral and Abbey Church of St Alban.

19 Nov 2010

Cough suppressant syrup may predict patients metabolise tamoxifen in breast cancer treatment

Cough medicine could be used as way of predicting how well individual patients metabolise tamoxifen used in the treatment of their breast cancer, according to new research presented at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Berlin today

19 Nov 2010

Threshold Pharmaceuticals announces results on TH-302 prodrug for cancers at EORTC-NCI-AACR Symposium

Threshold Pharmaceuticals, Inc. today announced clinical trial results related to Threshold's clinical stage hypoxia-activated prodrug, TH-302. The results were presented at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics taking place in Berlin, Germany from November 16 to19, 2010.

19 Nov 2010

Medical News

Substance abuse treatment facilities offering nicotine replacement therapy increased by 6%: Report

Insight Health Services sells seven imaging centers

Report examines how health care reform affects personal costs, coverage, quality of service

Glenn Foundation awards $60,000 grant to Scripps' scientist for biomedical research

Stromedix obtains license from UCSF for integrin αvβ5 antibody

MedStart Summer Enrichment Program helps students better understand medical conditions: Studies

SAMHSA: 4.8% U.S. adults suffer from serious mental illness

ENERCA network organizes European Symposium on rare anemias

Living in deprived area increases risk of violence more sharply for girls than boys: Study

AVEO's RON antibody shows anti-tumor activity in human cancer xenografts

Fifth gene defect, 47 DNA regions linked to thoracic aortic disease: Researchers

ZIOPHARM announces data on darinaparsin efficacy for solid tumors at EORTC-NCI-AACR Symposium

Acacia subsidiary receives patents for wireless physiological monitoring technology

ImmunoGen presents positive data on IMGN388 anticancer compound at EORTC-NCI-AACR Symposium

Physical activity may protect high-risk individuals from cognitive decline: Study

Research suggests new therapeutic approach to prevent transplant rejection

New handbooks provide health benefits information to Veterans

Illness perception related to concurrent depression symptoms: Research

Cough suppressant syrup may predict patients metabolise tamoxifen in breast cancer treatment

Threshold Pharmaceuticals announces results on TH-302 prodrug for cancers at EORTC-NCI-AACR Symposium

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News